Oficiálny časopis Slovenskej kardiologickej spoločnosti,
Slovenskej hypertenziologickej spoločnosti a Slovenskej asociácie srdcových arytmií

Cardiology Letters 2024, 33(1):61-64

Pulmonary hypertension in patients with advanced heart failure with reduced ejection fracion. Impact of the new definition of pulmonary hypertension

Samuel Vysocansky, Milan Luknar, Peter Lesny, Eva Goncalvesova
Hypertension Centre, Faculty of Medicine, Comenius University and National Institute of Cardiovascular Diseases, Bratislava, Slovak Republic

Uverejnené: January 1, 2024  Zobraziť citáciu

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vysocansky S, Luknar M, Lesny P, Goncalvesova E. Pulmonary hypertension in patients with advanced heart failure with reduced ejection fracion. Impact of the new definition of pulmonary hypertension. Cardiology Letters. 2024;33(1):61-64.
Share...
Stiahnuť citáciu
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobraziť celý článok

    Referencie

    1. Guha A, Amione-Guerra J, Park MH. Epidemiology of Pulmonary Hypertension in Left Heart Disease. Prog Cardiovasc Dis. 2016;59:3-10. doi: 10.1016/j.pcad.2016.07.001 Prejsť k pôvodnému zdroju...
    2. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. ESC/ERS Scientific Document Group. 2022 ESC/ ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:3618-3731. doi: 10.1093/eurheartj/ehac237 Prejsť k pôvodnému zdroju...
    3. Zeitouni M, Morlon Q, Silvain J, Procopi N, Guedeney P, Rouanet S, et al. Implication of the new definition of pulmonary hypertension in patients evaluated for heart transplantation. Int J Cardiol. 2023;384:18-24. doi: 10.1016/j.ijcard.2023.04.048. Prejsť k pôvodnému zdroju...
    4. Miller WL, Mahoney DW, Michelena HI, Pislaru SV, Topilsky Y, Enriquez-Sarano M. Contribution of ventricular diastolic dysfunction to pulmonary hypertension complicating chronic systolic heart failure. JACC Cardiovasc Imaging. 2011;4:946954. doi: 10.1016/j.jcmg.2011.06.017 Prejsť k pôvodnému zdroju...
    5. Cappola TP, Felker GM, Kao WH, Hare JM, Baughman KL, Kasper EK. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation. 2002;105:1663-8. doi: 10.1161/01.cir.0000013771.30198.82 Prejsť k pôvodnému zdroju...
    6. Miller WL, Grill DE, Borlaug BA. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. JACC Heart Fail. 2013;1:290-299. doi: 10.1016/j.jchf.2013.05.001 Prejsť k pôvodnému zdroju...
    7. Schmeißer A, Rauwolf T, Groscheck T, Fischbach K, Kropf S, Luani B, et al. Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction. ESC Heart Fail. 2021;8:2968-2981. doi: 10.1002/ehf2.13386 Prejsť k pôvodnému zdroju...
    8. Gerges M, Gerges C, Pistritto AM, Lang MB, Trip P, Jakowitsch J, et al. Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival. Am J Respir Crit Care Med. 2015;192:1234-1246. doi: 10.1164/rccm.201503-0529OC Prejsť k pôvodnému zdroju...

    Späť na obsah